2469 related articles for article (PubMed ID: 26306127)
1. The Left Atrial Appendage: Target for Stroke Reduction in Atrial Fibrillation.
Ramlawi B; Abu Saleh WK; Edgerton J
Methodist Debakey Cardiovasc J; 2015; 11(2):100-3. PubMed ID: 26306127
[TBL] [Abstract][Full Text] [Related]
2. Left Atrial Appendage Occlusion for Stroke Prevention.
Chanda A; Reilly JP
Prog Cardiovasc Dis; 2017; 59(6):626-635. PubMed ID: 28457791
[TBL] [Abstract][Full Text] [Related]
3. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
[TBL] [Abstract][Full Text] [Related]
5. Safety of percutaneous left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation and contraindications to anticoagulation.
Wiebe J; Bertog S; Franke J; Wettstein O; Lehn K; Hofmann I; Vaskelyte L; Sievert H
Catheter Cardiovasc Interv; 2014 Apr; 83(5):796-802. PubMed ID: 24327462
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous left atrial appendage closure: procedural techniques and outcomes.
Saw J; Lempereur M
JACC Cardiovasc Interv; 2014 Nov; 7(11):1205-20. PubMed ID: 25459035
[TBL] [Abstract][Full Text] [Related]
7. Bleeding Outcomes After Left Atrial Appendage Closure Compared With Long-Term Warfarin: A Pooled, Patient-Level Analysis of the WATCHMAN Randomized Trial Experience.
Price MJ; Reddy VY; Valderrábano M; Halperin JL; Gibson DN; Gordon N; Huber KC; Holmes DR
JACC Cardiovasc Interv; 2015 Dec; 8(15):1925-1932. PubMed ID: 26627989
[TBL] [Abstract][Full Text] [Related]
8. Safety profiles of percutaneous left atrial appendage closure devices: An analysis of the Food and Drug Administration Manufacturer and User Facility Device Experience (MAUDE) database from 2009 to 2016.
Jazayeri MA; Vuddanda V; Turagam MK; Parikh V; Lavu M; Atkins D; Earnest M; Di Biase L; Natale A; Wilber D; Reddy YM; Lakkireddy DR
J Cardiovasc Electrophysiol; 2018 Jan; 29(1):5-13. PubMed ID: 28988455
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous Left Atrial Appendage Ligation for Stroke Prevention in Atrial Fibrillation.
Valderrábano M; Price MJ
Methodist Debakey Cardiovasc J; 2015; 11(2):94-9. PubMed ID: 26306126
[TBL] [Abstract][Full Text] [Related]
10. Left atrial appendage closure.
Lin AC; Knight BP
Prog Cardiovasc Dis; 2015; 58(2):195-201. PubMed ID: 26241302
[TBL] [Abstract][Full Text] [Related]
11. Left atrial appendage exclusion: state-of-the-art.
Cruz-Gonzalez I; Yan BP; Lam YY
Catheter Cardiovasc Interv; 2010 Apr; 75(5):806-13. PubMed ID: 20088009
[TBL] [Abstract][Full Text] [Related]
12. Reduction in risk of stroke and bleeding after left atrial appendage closure with LARIAT device in patients with increased risk of stroke and bleeding: Long term results.
Litwinowicz R; Bartus M; Kapelak B; Suwalski P; Lakkireddy D; Lee RJ; Bartus K
Catheter Cardiovasc Interv; 2019 Nov; 94(6):837-842. PubMed ID: 30884101
[TBL] [Abstract][Full Text] [Related]
13. Mechanical closure devices for atrial fibrillation.
Price MJ; Holmes DR
Trends Cardiovasc Med; 2014 Aug; 24(6):225-31. PubMed ID: 25066488
[TBL] [Abstract][Full Text] [Related]
14. Left atrial appendage occlusion with the WATCHMAN™ for stroke prevention in atrial fibrillation.
Price MJ
Rev Cardiovasc Med; 2014; 15(2):142-51. PubMed ID: 25051131
[TBL] [Abstract][Full Text] [Related]
15. Left atrial appendage exclusion for stroke prevention in patients with nonrheumatic atrial fibrillation.
Onalan O; Crystal E
Stroke; 2007 Feb; 38(2 Suppl):624-30. PubMed ID: 17261703
[TBL] [Abstract][Full Text] [Related]
16. The role of multimodality imaging in percutaneous left atrial appendage suture ligation with the LARIAT device.
Laura DM; Chinitz LA; Aizer A; Holmes DS; Benenstein R; Freedberg RS; Kim EE; Saric M
J Am Soc Echocardiogr; 2014 Jul; 27(7):699-708. PubMed ID: 24874974
[TBL] [Abstract][Full Text] [Related]
17. The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy.
Viles-Gonzalez JF; Kar S; Douglas P; Dukkipati S; Feldman T; Horton R; Holmes D; Reddy VY
J Am Coll Cardiol; 2012 Mar; 59(10):923-9. PubMed ID: 22381428
[TBL] [Abstract][Full Text] [Related]
18. Initial experience of percutaneous left atrial appendage closure using the LAmbre device for thromboembolic prevention.
Reinsch N; Ruprecht U; Buchholz J; Edel C; Kälsch H; Neven K
J Cardiovasc Med (Hagerstown); 2018 Sep; 19(9):491-496. PubMed ID: 29894355
[TBL] [Abstract][Full Text] [Related]
19. Approaches to Left Atrial Appendage Closure: Device Design, Performance, and Limitations.
Dave AS; Valderrábano M
Methodist Debakey Cardiovasc J; 2017; 13(3):106-113. PubMed ID: 29743994
[TBL] [Abstract][Full Text] [Related]
20. Early Canadian Multicenter Experience With WATCHMAN for Percutaneous Left Atrial Appendage Closure.
Saw J; Fahmy P; Azzalini L; Marquis JF; Hibbert B; Morillo C; Carrizo A; Ibrahim R
J Cardiovasc Electrophysiol; 2017 Apr; 28(4):396-401. PubMed ID: 28128883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
